COVID-19

"Robust Immune Responses": Indian Vaccine-Maker After Test On Monkeys

Bharat Biotech that is developing the coronavirus vaccine COVAXIN in its latest report has said an animal study has shown a vaccine candidate has helped develop a strong immune response to the highly infectious coronavirus. “To summarise, the vaccine candidate was found to generate robust immune responses. Thus, preventing infection and disease in the primates upon high amounts of exposure to live SARS-CoV-2 virus,” Bharat Biotech posted on its website.

NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe for more videos:
Like us on Facebook:
Follow us on Twitter:
Download the NDTV Apps:
Watch more videos: